E. Claypoole Robert's Insider Trades & SAST Disclosures
E. Claypoole Robert's most recent trade in Bioventus Inc - Ordinary Shares - Class A was a trade of 28,786 Class A Common Stock done at an average price of $9.1 . Disclosure was reported to the exchange on Jan. 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern E. Claypoole Robert.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bioventus Inc - Ordinary S... | Robert E. Claypoole | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.10 per share. | 13 Jan 2025 | 28,786 | 64,964 (0%) | 0% | 9.1 | 261,953 | Class A Common Stock |
| Bioventus Inc - Ordinary S... | Robert E. Claypoole | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2025 | 93,750 | 93,750 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Robert E. Claypoole | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2025 | 93,750 | 281,250 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Robert Claypoole E. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 850,000 | 850,000 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc - Ordinary S... | E. Claypoole Robert | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 375,000 | 375,000 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges